Liangzhi Xie

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Sinocelltech Group (China), Sino Biological (China), Research & Diagnostic Antibodies (United States)

发表论文 2 篇 · 总被引 2 次 · h-index 1

代表论文

• Population Pharmacokinetics of SCT510 (a Bevacizumab Biosimilar) and Avastin® in Healthy Subjects and Patients with Non-squamous Non-small Cell Lung Cancer (2026 · Clinical Drug Investigation · 被引 2)
• TOI-IGRA: A Fingertip Blood Biosensing Technology for Decentralized Quantification of Pathogen-Specific T-Cell Responses (2026 · Analytical Chemistry)